Allspring Global Investments
FBIO icon

Allspring Global Investments’s Fortress Biotech FBIO Stock Holding History

Allspring Global Investments’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,756
Closed -$199K – 2759
2022
Q1 		$199K Buy
9,756
+1,081
+12% +$29.6K ﹤0.01% 2571
2021
Q4 		$325K Buy
+8,675
New +$387K ﹤0.01% 2471

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Allspring Global Investments's FBIO Position: Q2 2022 in Review

Allspring Global Investments sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 9,756 shares — an estimated $199K sold.

Allspring Global Investments first reported a position in FBIO in Q4 2021 and held it in 2 quarters. The position peaked at $325K in Q4 2021. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

  • Allspring Global Investments reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 9,756 Fortress Biotech shares in Q2 2022, an estimated $199K.
  • Allspring Global Investments first reported a position in Fortress Biotech in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Fortress Biotech position peaked at $325K in Q4 2021.
  • 66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.